House hearing on silicone breast implants
This article was originally published in Clinica
Executive Summary
The US FDA remains unconvinced that silicone gel-filled breast implants are safe. Although there is no hard evidence that the products cause autoimmune diseases or rheumatologic disorders, the agency is strictly limiting use of the implants. They may be given only as part of clinical trials, for reconstructive surgery and a few augmentative procedures. Last Tuesday, Congress wanted to know why. Clinica's Washington correspondent, Duffy Miller, reports from the August 1st House hearings on Capitol Hill.